The Polit Bureau took serious note of the fact that the United States has sought to pressurize India on the Indian Patent law and Intellectual Property Rights policy. It also sought the dilution of the civil nuclear liability law of the country. Both these are reflected in the joint statement issued by Prime Minister Modi and President Obama. The joint statement announced the decision to set up an Intellectual Property Working Group. The US pharmaceutical companies have been demanding that India dilute its present patent regime which has utilised the flexibilities provided in the TRIPS agreement. It is this which helps to keep drug prices low for the people in India.